Sotera Health Company (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Analysts

Sotera Health Company (NASDAQ:SHC) has been assigned a consensus recommendation of “Moderate Buy” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $20.00.

SHC has been the subject of several recent analyst reports. William Blair assumed coverage on Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating for the company. BMO Capital Markets began coverage on Sotera Health in a report on Thursday, November 13th. They set an “outperform” rating and a $19.00 price objective for the company. Wells Fargo & Company downgraded shares of Sotera Health to an “overweight” rating in a research note on Thursday, January 8th. Royal Bank Of Canada began coverage on shares of Sotera Health in a research report on Thursday, January 8th. They set an “outperform” rating and a $24.00 target price for the company. Finally, Zacks Research raised shares of Sotera Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 1st.

Insiders Place Their Bets

In other news, Director Gtcr Investment Xi Llc sold 6,480,000 shares of Sotera Health stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total value of $105,818,400.00. Following the transaction, the director owned 22,735,301 shares in the company, valued at approximately $371,267,465.33. The trade was a 22.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Pincus & Co. Warburg sold 9,720,000 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total value of $158,727,600.00. Following the sale, the director directly owned 34,102,952 shares of the company’s stock, valued at approximately $556,901,206.16. This trade represents a 22.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 29,384,104 shares of company stock valued at $471,824,511 over the last three months. Insiders own 47.55% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

Institutional investors and hedge funds have recently made changes to their positions in the business. UMB Bank n.a. increased its stake in Sotera Health by 112.8% during the 2nd quarter. UMB Bank n.a. now owns 2,635 shares of the company’s stock valued at $29,000 after purchasing an additional 1,397 shares in the last quarter. True Wealth Design LLC increased its position in shares of Sotera Health by 389.3% during the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after acquiring an additional 1,456 shares in the last quarter. Parallel Advisors LLC raised its holdings in Sotera Health by 124.0% in the 2nd quarter. Parallel Advisors LLC now owns 3,340 shares of the company’s stock worth $37,000 after acquiring an additional 1,849 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Sotera Health by 831.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after acquiring an additional 2,935 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Sotera Health by 33.1% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 3,583 shares of the company’s stock valued at $40,000 after purchasing an additional 892 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Down 0.4%

Shares of SHC stock opened at $18.90 on Friday. Sotera Health has a 52-week low of $9.53 and a 52-week high of $19.85. The company has a 50-day simple moving average of $17.50 and a two-hundred day simple moving average of $15.79. The company has a debt-to-equity ratio of 4.04, a quick ratio of 2.18 and a current ratio of 2.38. The company has a market capitalization of $5.37 billion, a price-to-earnings ratio of 99.48 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Tuesday, November 4th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.The firm had revenue of $311.31 million during the quarter, compared to analyst estimates of $303.63 million. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. Research analysts anticipate that Sotera Health will post 0.61 EPS for the current fiscal year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.